• Preguntas frecuentes
  • Glosario
Cerrar

Preguntas frecuentes

Why are animal models used when testing the safety of a new therapy?
What role do preclinical and clinical trials play in ensuring patient safety?
Why are some conditions more suitable for gene and cell therapies than others?
There is an approved treatment available for my condition - why can't I receive it?
How to look for approved medicines?
How are medicines developed and approved?

Ver todas las preguntas frecuentes

Cerrar

Glosario

Accelerated assessment
Adeno-associated virus (AAV)
Adenovirus
Adult stem cells
Advanced Therapy Investigational Medicinal Product (ATIMP)
Advanced Therapy Medicinal Product (ATMP)
Advertising 
Antibody
Antigen
Base editors

Ver el glosario completo

Improving patient access to gene and cell therapies for rare diseases in Europe.

In this report, EURODIS reviews the challenges and proposals for improving patient access to advanced therapeutic medicinal products in England. 
 

Última actualización:

Volver arriba
¿Le pareció útil el contenido de esta página? Envianos tus comentarios